Trial Profile
Bioequivalence of the 40 mg Telmisartan Film-coated Tablet Compared With the Conventional 40 mg Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Cardiovascular disorders; Essential hypertension; Hypertension; Metabolic syndrome
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 22 Oct 2014 New trial record